To improve sensitivity, specificity, and reproducibility of HER2 status evaluation, pathologists need to be aware of the molecular mechanisms underlying the variable expression of HER2 in different types of breast cancers and even in different cells within the same tumor. The gene discussed is ERBB2; the disease is breast carcinoma.